Saul J Priceman

Title(s)Visiting Associate Professor of Medicine
SchoolKeck School of Medicine of Usc
Address1441 Eastlake Ave.
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard
    Other Positions
    Title(s)Director of the KSOM/NCCC Center for Cancer Cellular Immunotherapy Research


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial. Nat Med. 2024 Jun; 30(6):1636-1644. Dorff TB, Blanchard MS, Adkins LN, Luebbert L, Leggett N, Shishido SN, Macias A, Del Real MM, Dhapola G, Egelston C, Murad JP, Rosa R, Paul J, Chaudhry A, Martirosyan H, Gerdts E, Wagner JR, Stiller T, Tilakawardane D, Pal S, Martinez C, Reiter RE, Budde LE, D'Apuzzo M, Kuhn P, Pachter L, Forman SJ, Priceman SJ. PMID: 38867077; PMCID: PMC11186768.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    2. Using Oncolytic Virus to Retask CD19-Chimeric Antigen Receptor T Cells for Treatment of Pancreatic Cancer: Toward a Universal Chimeric Antigen Receptor T-Cell Strategy for Solid Tumor. J Am Coll Surg. 2024 Apr 01; 238(4):436-447. Chen C, Park AK, Monroy I, Ren Y, Kim SI, Chaurasiya S, Priceman SJ, Fong Y. PMID: 38214445.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    3. Nonsignaling extracellular spacer regulates tumor antigen selectivity of CAR T cells. Mol Ther Oncol. 2024 Jun 20; 32(2):200789. Kennewick KT, Yamaguchi Y, Gibson J, Gerdts EA, Jeang B, Tilakawardane D, Murad JP, Chang WC, Wright SL, Thiel MS, Forman SJ, Stern LA, Priceman SJ. PMID: 38939825; PMCID: PMC11208731.
      View in: PubMed   Mentions:
    4. Regulation of nuclear transcription by mitochondrial RNA in endothelial cells. Elife. 2024 Jan 22; 13. Sriram K, Qi Z, Yuan D, Malhi NK, Liu X, Calandrelli R, Luo Y, Tapia A, Jin S, Shi J, Salas M, Dang R, Armstrong B, Priceman SJ, Wang PH, Liao J, Natarajan R, Zhong S, Bouman Chen Z. PMID: 38251974; PMCID: PMC10803041.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    5. Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rα expression. Mol Ther. 2024 Feb 07; 32(2):527-539. Munoz AM, Urak R, Taus E, Hsieh HJ, Awuah D, Vyas V, Lim L, Jin K, Lin SH, Priceman SJ, Clark MC, Goldberg L, Forman SJ, Wang X. PMID: 38140726; PMCID: PMC10861975.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    6. Chimeric Antigen Receptor-T Cell and Oncolytic Viral Therapies for Gastric Cancer and Peritoneal Carcinomatosis of Gastric Origin: Path to Improving Combination Strategies. Cancers (Basel). 2023 Nov 30; 15(23). Chen C, Jung A, Yang A, Monroy I, Zhang Z, Chaurasiya S, Deshpande S, Priceman S, Fong Y, Park AK, Woo Y. PMID: 38067366; PMCID: PMC10705752.
      View in: PubMed   Mentions:
    7. Expansion of endogenous T cells in CSF of pediatric CNS tumor patients undergoing locoregional delivery of IL13R〿2-targeting CAR T cells: an interim analysis. Res Sq. 2023 Oct 23. Wang L, Oill AT, Blanchard M, Wu M, Hibbard J, Sepulveda S, Peter L, Kilpatrick J, Munoz M, Stiller T, Shulkin N, Wagner J, Dolatabadi A, Nisis M, Shepphird J, Sanchez G, Lingaraju C, Manchanda M, Natri H, Kouakanou L, Sun G, Oliver-Cervantes C, Georges J, Aftabizadeh M, Forman S, Priceman S, Ressler J, Arvanitis L, Cotter J, D'Apuzzo M, Tamrazi B, Badie B, Davidson T, Banovich N, Brown C. PMID: 37961215; PMCID: PMC10635314.
      View in: PubMed   Mentions:
    8. Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting. Nat Commun. 2023 08 07; 14(1):4737. Lee EHJ, Murad JP, Christian L, Gibson J, Yamaguchi Y, Cullen C, Gumber D, Park AK, Young C, Monroy I, Yang J, Stern LA, Adkins LN, Dhapola G, Gittins B, Chang WC, Martinez C, Woo Y, Cristea M, Rodriguez-Rodriguez L, Ishihara J, Lee JK, Forman SJ, Wang LD, Priceman SJ. PMID: 37550294; PMCID: PMC10406808.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    9. Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy. Nat Commun. 2023 04 11; 14(1):2041. Bhatia V, Kamat NV, Pariva TE, Wu LT, Tsao A, Sasaki K, Sun H, Javier G, Nutt S, Coleman I, Hitchcock L, Zhang A, Rudoy D, Gulati R, Patel RA, Roudier MP, True LD, Srivastava S, Morrissey CM, Haffner MC, Nelson PS, Priceman SJ, Ishihara J, Lee JK. PMID: 37041154; PMCID: PMC10090190.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    10. Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastases. J Immunother Cancer. 2023 04; 11(4). Yang A, Zhang Z, Chaurasiya S, Park AK, Jung A, Lu J, Kim SI, Priceman S, Fong Y, Woo Y. PMID: 37019471; PMCID: PMC10083877.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    11. Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting. bioRxiv. 2023 Jan 07. Jun Lee EH, Cullen C, Murad JP, Gumber D, Park AK, Yang J, Stern LA, Adkins LN, Dhapola G, Gittins B, Chung-Chang W, Martinez C, Woo Y, Cristea M, Rodriguez-Rodriguez L, Ishihara J, Lee JK, Forman SJ, Wang LD, Priceman SJ. PMID: 36711615; PMCID: PMC9881930.
      View in: PubMed   Mentions:
    12. PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages. J Immunother Cancer. 2022 06; 10(6). Yamaguchi Y, Gibson J, Ou K, Lopez LS, Ng RH, Leggett N, Jonsson VD, Zarif JC, Lee PP, Wang X, Martinez C, Dorff TB, Forman SJ, Priceman SJ. PMID: 35738799; PMCID: PMC9226933.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    13. Advancing together and moving forward: Combination gene and cellular immunotherapies. Mol Ther Oncolytics. 2022 Jun 16; 25:330-334. Priceman SJ, Cheema W, Adusumilli PS. PMID: 35694448; PMCID: PMC9160651.
      View in: PubMed   Mentions: 2  
    14. Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer. JCO Precis Oncol. 2022 03; 6:e2100239. Dellinger TH, Han ES, Raoof M, Lee B, Wu X, Cho H, He TF, Lee P, Razavi M, Liang WS, Schmolze D, Priceman SJ, Lee S, Lin WC, Lin JF, Kebria M, Hakim A, Ruel N, Stewart DB, Wang EW, Paz BI, Wakabayashi MT, Cristea MC, Rodriguez-Rodriguez L. PMID: 35357903; PMCID: PMC8984280.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    15. Novel Redirected T-Cell Immunotherapies for Advanced Prostate Cancer. Clin Cancer Res. 2022 02 15; 28(4):576-584. Dorff TB, Narayan V, Forman SJ, Zang PD, Fraietta JA, June CH, Haas NB, Priceman SJ. PMID: 34675084; PMCID: PMC8866199.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    16. Off-the-Shelf Prostate Stem Cell Antigen-Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancreatic Cancer. Gastroenterology. 2022 04; 162(4):1319-1333. Teng KY, Mansour AG, Zhu Z, Li Z, Tian L, Ma S, Xu B, Lu T, Chen H, Hou D, Zhang J, Priceman SJ, Caligiuri MA, Yu J. PMID: 34999097; PMCID: PMC8963130.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    17. Enhanced intratumoural activity of CAR T cells engineered to produce immunomodulators under photothermal control. Nat Biomed Eng. 2021 11; 5(11):1348-1359. Miller IC, Zamat A, Sun LK, Phuengkham H, Harris AM, Gamboa L, Yang J, Murad JP, Priceman SJ, Kwong GA. PMID: 34385695; PMCID: PMC8791016.
      View in: PubMed   Mentions: 49     Fields:    Translation:AnimalsCells
    18. Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity. Mol Ther. 2021 07 07; 29(7):2335-2349. Murad JP, Tilakawardane D, Park AK, Lopez LS, Young CA, Gibson J, Yamaguchi Y, Lee HJ, Kennewick KT, Gittins BJ, Chang WC, Tran CP, Martinez C, Wu AM, Reiter RE, Dorff TB, Forman SJ, Priceman SJ. PMID: 33647456; PMCID: PMC8261088.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    19. Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity. Mol Cancer Ther. 2021 01; 20(1):173-182. Kim SI, Park AK, Chaurasiya S, Kang S, Lu J, Yang A, Sivanandam V, Zhang Z, Woo Y, Priceman SJ, Fong Y, Warner SG. PMID: 33262221; PMCID: PMC7790874.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    20. The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma. Cancer Immunol Res. 2021 01; 9(1):75-88. Wang X, Huynh C, Urak R, Weng L, Walter M, Lim L, Vyas V, Chang WC, Aguilar B, Brito A, Sarkissian A, Bandara NA, Yang L, Wang J, Wu X, Zhang J, Priceman SJ, Qin H, Kwak LW, Budde LE, Thomas SH, Clark MC, Popplewell L, Siddiqi T, Brown CE, Forman SJ. PMID: 33093217; PMCID: PMC8008993.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    21. Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors. Sci Transl Med. 2020 09 02; 12(559). Park AK, Fong Y, Kim SI, Yang J, Murad JP, Lu J, Jeang B, Chang WC, Chen NG, Thomas SH, Forman SJ, Priceman SJ. PMID: 32878978; PMCID: PMC9126033.
      View in: PubMed   Mentions: 98     Fields:    Translation:AnimalsCells
    22. CAR T Cell Therapy Progress and Challenges for Solid Tumors. Cancer Treat Res. 2020; 180:297-326. Stern LA, Jonsson VD, Priceman SJ. PMID: 32215875.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    23. STAT3 Activation-Induced Fatty Acid Oxidation in CD8+ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth. Cell Metab. 2020 01 07; 31(1):148-161.e5. Zhang C, Yue C, Herrmann A, Song J, Egelston C, Wang T, Zhang Z, Li W, Lee H, Aftabizadeh M, Li YJ, Lee PP, Forman S, Somlo G, Chu P, Kruper L, Mortimer J, Hoon DSB, Huang W, Priceman S, Yu H. PMID: 31761565; PMCID: PMC6949402.
      View in: PubMed   Mentions: 150     Fields:    Translation:HumansAnimalsCells
    24. Precision Medicine-Enabled Cancer Immunotherapy. Cancer Treat Res. 2019; 178:189-205. Lee JK, Priceman SJ. PMID: 31209846.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    25. Effective Targeting of TAG72+ Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells. Front Immunol. 2018; 9:2268. Murad JP, Kozlowska AK, Lee HJ, Ramamurthy M, Chang WC, Yazaki P, Colcher D, Shively J, Cristea M, Forman SJ, Priceman SJ. PMID: 30510550; PMCID: PMC6254427.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansAnimalsCells
    26. PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with 89Zr-Oxine. J Nucl Med. 2018 10; 59(10):1531-1537. Weist MR, Starr R, Aguilar B, Chea J, Miles JK, Poku E, Gerdts E, Yang X, Priceman SJ, Forman SJ, Colcher D, Brown CE, Shively JE. PMID: 29728514; PMCID: PMC6167529.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansAnimalsCells
    27. Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2+ Breast Cancer Metastasis to the Brain. Clin Cancer Res. 2018 01 01; 24(1):95-105. Priceman SJ, Tilakawardane D, Jeang B, Aguilar B, Murad JP, Park AK, Chang WC, Ostberg JR, Neman J, Jandial R, Portnow J, Forman SJ, Brown CE. PMID: 29061641; PMCID: PMC7685198.
      View in: PubMed   Mentions: 161     Fields:    Translation:HumansAnimalsCells
    28. Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer. Oncoimmunology. 2018; 7(2):e1380764. Priceman SJ, Gerdts EA, Tilakawardane D, Kennewick KT, Murad JP, Park AK, Jeang B, Yamaguchi Y, Yang X, Urak R, Weng L, Chang WC, Wright S, Pal S, Reiter RE, Wu AM, Brown CE, Forman SJ. PMID: 29308300; PMCID: PMC5749625.
      View in: PubMed   Mentions: 77     Fields:    
    29. Sphingosine-1-Phosphate Receptor-1 Promotes Environment-Mediated and Acquired Chemoresistance. Mol Cancer Ther. 2017 11; 16(11):2516-2527. Lifshitz V, Priceman SJ, Li W, Cherryholmes G, Lee H, Makovski-Silverstein A, Borriello L, DeClerck YA, Yu H. PMID: 28716816; PMCID: PMC5669816.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    30. Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy. N Engl J Med. 2016 12 29; 375(26):2561-9. Brown CE, Alizadeh D, Starr R, Weng L, Wagner JR, Naranjo A, Ostberg JR, Blanchard MS, Kilpatrick J, Simpson J, Kurien A, Priceman SJ, Wang X, Harshbarger TL, D'Apuzzo M, Ressler JA, Jensen MC, Barish ME, Chen M, Portnow J, Forman SJ, Badie B. PMID: 28029927; PMCID: PMC5390684.
      View in: PubMed   Mentions: 873     Fields:    Translation:HumansCellsCTClinical Trials
    31. Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey-Holden Prostate Cancer Academy Meeting. Prostate. 2017 02; 77(2):123-144. Miyahira AK, Roychowdhury S, Goswami S, Ippolito JE, Priceman SJ, Pritchard CC, Sfanos KS, Subudhi SK, Simons JW, Pienta KJ, Soule HR. PMID: 27679977.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    32. Targeting Alpha-Fetoprotein (AFP)-MHC Complex with CAR T-Cell Therapy for Liver Cancer. Clin Cancer Res. 2017 Jan 15; 23(2):478-488. Liu H, Xu Y, Xiang J, Long L, Green S, Yang Z, Zimdahl B, Lu J, Cheng N, Horan LH, Liu B, Yan S, Wang P, Diaz J, Jin L, Nakano Y, Morales JF, Zhang P, Liu LX, Staley BK, Priceman SJ, Brown CE, Forman SJ, Chan VW, Liu C. PMID: 27535982.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansAnimalsCells
    33. L1 Cell Adhesion Molecule-Specific Chimeric Antigen Receptor-Redirected Human T Cells Exhibit Specific and Efficient Antitumor Activity against Human Ovarian Cancer in Mice. PLoS One. 2016; 11(1):e0146885. Hong H, Brown CE, Ostberg JR, Priceman SJ, Chang WC, Weng L, Lin P, Wakabayashi MT, Jensen MC, Forman SJ. PMID: 26761817; PMCID: PMC4711972.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    34. Smart CARs engineered for cancer immunotherapy. Curr Opin Oncol. 2015 Nov; 27(6):466-74. Priceman SJ, Forman SJ, Brown CE. PMID: 26352543; PMCID: PMC4659816.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    35. CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells. J Clin Invest. 2015 Jun; 125(6):2547. Herrmann A, Priceman SJ, Swiderski P, Kujawski M, Xin H, Cherryholmes GA, Zhang W, Zhang C, Lahtz C, Kowolik C, Forman SJ, Kortylewski M, Yu H. PMID: 26030229; PMCID: PMC4518694.
      View in: PubMed   Mentions: 8     Fields:    
    36. STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis. Cancer Immunol Res. 2015 Aug; 3(8):864-870. Yue C, Shen S, Deng J, Priceman SJ, Li W, Huang A, Yu H. PMID: 26025380; PMCID: PMC4527884.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimalsCells
    37. CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy. Cancer Res. 2015 Mar 15; 75(6):950-62. Escamilla J, Schokrpur S, Liu C, Priceman SJ, Moughon D, Jiang Z, Pouliot F, Magyar C, Sung JL, Xu J, Deng G, West BL, Bollag G, Fradet Y, Lacombe L, Jung ME, Huang J, Wu L. PMID: 25736687; PMCID: PMC4359956.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansAnimalsCells
    38. CD8+ T-cell immunosurveillance constrains lymphoid premetastatic myeloid cell accumulation. Eur J Immunol. 2015 Jan; 45(1):71-81. Zhang W, Zhang C, Li W, Deng J, Herrmann A, Priceman SJ, Liang W, Shen S, Pal SK, Hoon DSB, Yu H. PMID: 25310972; PMCID: PMC4293284.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    39. Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacy. Mol Ther. 2015 Apr; 23(4):757-68. Jonnalagadda M, Mardiros A, Urak R, Wang X, Hoffman LJ, Bernanke A, Chang WC, Bretzlaff W, Starr R, Priceman S, Ostberg JR, Forman SJ, Brown CE. PMID: 25366031; PMCID: PMC4395772.
      View in: PubMed   Mentions: 118     Fields:    Translation:AnimalsCells
    40. CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells. J Clin Invest. 2014 Jul; 124(7):2977-87. Herrmann A, Priceman SJ, Swiderski P, Kujawski M, Xin H, Cherryholmes GA, Zhang W, Zhang C, Lahtz C, Kowolik C, Forman SJ, Kortylewski M, Yu H. PMID: 24892807; PMCID: PMC4071407.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansAnimalsCells
    41. Pten null prostate epithelium promotes localized myeloid-derived suppressor cell expansion and immune suppression during tumor initiation and progression. Mol Cell Biol. 2014 Jun; 34(11):2017-28. Garcia AJ, Ruscetti M, Arenzana TL, Tran LM, Bianci-Frias D, Sybert E, Priceman SJ, Wu L, Nelson PS, Smale ST, Wu H. PMID: 24662052; PMCID: PMC4019050.
      View in: PubMed   Mentions: 78     Fields:    Translation:AnimalsCells
    42. S1PR1 is crucial for accumulation of regulatory T cells in tumors via STAT3. Cell Rep. 2014 Mar 27; 6(6):992-999. Priceman SJ, Shen S, Wang L, Deng J, Yue C, Kujawski M, Yu H. PMID: 24630990; PMCID: PMC3988983.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimalsCells
    43. Icaritin inhibits JAK/STAT3 signaling and growth of renal cell carcinoma. PLoS One. 2013; 8(12):e81657. Li S, Priceman SJ, Xin H, Zhang W, Deng J, Liu Y, Huang J, Zhu W, Chen M, Hu W, Deng X, Zhang J, Yu H, He G. PMID: 24324713; PMCID: PMC3855768.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimalsCells
    44. Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A. 2013 Aug 06; 110(32):13079-84. Priceman SJ, Kujawski M, Shen S, Cherryholmes GA, Lee H, Zhang C, Kruper L, Mortimer J, Jove R, Riggs AD, Yu H. PMID: 23878227; PMCID: PMC3740863.
      View in: PubMed   Mentions: 59     Fields:    Translation:AnimalsCells
    45. CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer. Cancer Res. 2013 May 01; 73(9):2782-94. Xu J, Escamilla J, Mok S, David J, Priceman S, West B, Bollag G, McBride W, Wu L. PMID: 23418320; PMCID: PMC4097014.
      View in: PubMed   Mentions: 316     Fields:    Translation:HumansAnimalsCells
    46. S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell. 2012 May 15; 21(5):642-654. Deng J, Liu Y, Lee H, Herrmann A, Zhang W, Zhang C, Shen S, Priceman SJ, Kujawski M, Pal SK, Raubitschek A, Hoon DSB, Forman S, Figlin RA, Liu J, Jove R, Yu H. PMID: 22624714; PMCID: PMC3360884.
      View in: PubMed   Mentions: 132     Fields:    Translation:HumansAnimalsCells
    47. In vivo imaging of intraprostatic-specific gene transcription by PET. J Nucl Med. 2011 May; 52(5):784-91. Pouliot F, Karanikolas BD, Johnson M, Sato M, Priceman SJ, Stout D, Sohn J, Satyamurthy N, deKernion JB, Wu L. PMID: 21498525; PMCID: PMC3173510.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    48. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010 Sep 15; 70(18):7042-52. Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, Arevalo JM, Morizono K, Karanikolas BD, Wu L, Sood AK, Cole SW. PMID: 20823155; PMCID: PMC2940980.
      View in: PubMed   Mentions: 377     Fields:    Translation:AnimalsCells
    49. Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels. Mol Genet Metab. 2010 Sep; 101(1):66-75. Imaizumi S, Grijalva V, Priceman S, Wu L, Su F, Farias-Eisner R, Hama S, Navab M, Fogelman AM, Reddy ST. PMID: 20619710; PMCID: PMC3037189.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    50. Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy. Blood. 2010 Feb 18; 115(7):1461-71. Priceman SJ, Sung JL, Shaposhnik Z, Burton JB, Torres-Collado AX, Moughon DL, Johnson M, Lusis AJ, Cohen DA, Iruela-Arispe ML, Wu L. PMID: 20008303; PMCID: PMC2826767.
      View in: PubMed   Mentions: 190     Fields:    Translation:AnimalsCells
    51. A novel intracellular protein delivery platform based on single-protein nanocapsules. Nat Nanotechnol. 2010 Jan; 5(1):48-53. Yan M, Du J, Gu Z, Liang M, Hu Y, Zhang W, Priceman S, Wu L, Zhou ZH, Liu Z, Segura T, Tang Y, Lu Y. PMID: 19935648.
      View in: PubMed   Mentions: 111     Fields:    Translation:HumansAnimalsCells
    52. Absence of myeloid COX-2 attenuates acute inflammation but does not influence development of atherosclerosis in apolipoprotein E null mice. Arterioscler Thromb Vasc Biol. 2010 Feb; 30(2):260-8. Narasimha AJ, Watanabe J, Ishikawa TO, Priceman SJ, Wu L, Herschman HR, Reddy ST. PMID: 19926832; PMCID: PMC2859183.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    53. Titration of variant HSV1-tk gene expression to determine the sensitivity of 18F-FHBG PET imaging in a prostate tumor. J Nucl Med. 2009 May; 50(5):757-64. Johnson M, Karanikolas BD, Priceman SJ, Powell R, Black ME, Wu HM, Czernin J, Huang SC, Wu L. PMID: 19372484; PMCID: PMC2805178.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    54. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer Res. 2008 Oct 01; 68(19):7828-37. Burton JB, Priceman SJ, Sung JL, Brakenhielm E, An DS, Pytowski B, Alitalo K, Wu L. PMID: 18829538; PMCID: PMC2800077.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansAnimalsCells
    55. ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia. Blood. 2007 Apr 15; 109(8):3400-8. Shankar DB, Li J, Tapang P, Owen McCall J, Pease LJ, Dai Y, Wei RQ, Albert DH, Bouska JJ, Osterling DJ, Guo J, Marcotte PA, Johnson EF, Soni N, Hartandi K, Michaelides MR, Davidsen SK, Priceman SJ, Chang JC, Rhodes K, Shah N, Moore TB, Sakamoto KM, Glaser KB. PMID: 17209055; PMCID: PMC1852258.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    56. Calcium-dependent upregulation of E4BP4 expression correlates with glucocorticoid-evoked apoptosis of human leukemic CEM cells. Biochem Biophys Res Commun. 2006 Jun 02; 344(2):491-9. Priceman SJ, Kirzner JD, Nary LJ, Morris D, Shankar DB, Sakamoto KM, Medh RD. PMID: 16630563; PMCID: PMC2763529.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    Saul's Networks
    Concepts (298)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (19)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.